Category: 56241-09-9

Reference of 56241-09-9, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 56241-09-9, Name is 4-Chloro-1(2H)-isoquinolone, molecular formula is C9H6ClNO. In a Patent，once mentioned of 56241-09-9

Compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N=C(NH2)2 or NHC(=NH)NH2, and the other substituents are as defined herein, are urokinase (uPA) inhibitors.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Reference of 56241-09-9. In my other articles, you can also check out more blogs about 56241-09-9

Reference：
Isoquinoline – Wikipedia,
Isoquinoline | C9H2140N – PubChem

 

Related Products of 56241-09-9, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.56241-09-9, Name is 4-Chloro-1(2H)-isoquinolone, molecular formula is C9H6ClNO. In a Patent£¬once mentioned of 56241-09-9

Isoquinolines

Isoquinolinylguanidine compounds of formula (I): STR1 wherein the substituents are as defined herein, and salts thereof, are disclosed as urokinase inhibitors.

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 56241-09-9, and how the biochemistry of the body works.Related Products of 56241-09-9

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

One of the major reasons for studying chemical kinetics is to use measurements of the macroscopic properties of a system, category: isoquinoline, such as the rate of change in the concentration of reactants or products with time.In a article, mentioned the application of 56241-09-9, Name is 4-Chloro-1(2H)-isoquinolone, molecular formula is C9H6ClNO

Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines

1-Isoquinolinylguanidines were previously disclosed as potent and selective inhibitors of urokinase-type plasminogen activator (uPA). Further investigation of this template has revealed that incorporation of a 7-sulfonamide group furnishes a new series of potent and highly selective uPA inhibitors. Potency and selectivity can be achieved with sulfonamides derived from a variety of amines and is further enhanced by the incorporation of sulfonamides derived from amino acids. The binding mode of these 1-isoquinolinylguanidines has been investigated by X-ray cocrystallization studies. uPA inhibitor 26 was selected for further evaluation based on its excellent enzyme potency (Ki 10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin). In vitro, compound 26 is able to inhibit exogenous uPA in human chronic wound fluid (IC50 = 0.89 muM). In vivo, in a porcine acute excisional wound model, following topical delivery, compound 26 is able to penetrate into pig wounds and inhibit exogenous uPA activity with no adverse effect on wound healing parameters. On the basis of this profile, compound 26 (UK-371,804) was selected as a candidate for further preclinical evaluation for the treatment of chronic dermal ulcers.

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, category: isoquinoline, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 56241-09-9

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem